GENEVA, Sept. 7 -- INNOVENT BIOLOGICS (SUZHOU) CO., LTD. filed a patent application (CN2025/109104) for “ANTI-CDH17/EGFR/CD16A TRISPECIFIC ANTIBODY AND USE THEREOF”. With publication no. WO/2026/017120, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....